BioMark Diagnostics Inc. (BMKDF)
USD 0.18
(0.0%)
USD 0.18
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 1.08 Million CAD | 48.7% |
| 2023 | 732.29 Thousand CAD | -50.24% |
| 2022 | 1.47 Million CAD | 54.43% |
| 2021 | 952.93 Thousand CAD | 49.53% |
| 2020 | 637.29 Thousand CAD | 1739.66% |
| 2019 | 34.64 Thousand CAD | -33.05% |
| 2018 | 51.74 Thousand CAD | 30.76% |
| 2017 | 39.57 Thousand CAD | 17.19% |
| 2016 | 33.76 Thousand CAD | -85.34% |
| 2015 | 230.33 Thousand CAD | 150.36% |
| 2014 | 92 Thousand CAD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 1.34 Million CAD | 113.41% |
| 2024 Q1 | 722.8 Thousand CAD | -1.29% |
| 2024 Q2 | 632.23 Thousand CAD | -12.53% |
| 2024 Q4 | 1.08 Million CAD | -19.29% |
| 2024 FY | 1.08 Million CAD | 48.7% |
| 2023 FY | 732.29 Thousand CAD | -50.24% |
| 2023 Q3 | 884.59 Thousand CAD | -12.23% |
| 2023 Q4 | 732.29 Thousand CAD | -17.22% |
| 2023 Q2 | 1 Million CAD | -22.83% |
| 2023 Q1 | 1.3 Million CAD | -11.24% |
| 2022 Q3 | 1.39 Million CAD | 120.96% |
| 2022 Q1 | 758.16 Thousand CAD | -20.44% |
| 2022 FY | 1.47 Million CAD | 54.43% |
| 2022 Q4 | 1.47 Million CAD | 5.79% |
| 2022 Q2 | 629.55 Thousand CAD | -16.96% |
| 2021 Q4 | 952.93 Thousand CAD | 135.76% |
| 2021 FY | 952.93 Thousand CAD | 49.53% |
| 2021 Q1 | 533.28 Thousand CAD | -16.32% |
| 2021 Q3 | 404.19 Thousand CAD | -17.55% |
| 2021 Q2 | 490.21 Thousand CAD | -8.08% |
| 2020 FY | 637.29 Thousand CAD | 1739.66% |
| 2020 Q4 | 637.29 Thousand CAD | -14.23% |
| 2020 Q3 | 743.04 Thousand CAD | 830.85% |
| 2020 Q2 | 79.82 Thousand CAD | -54.3% |
| 2020 Q1 | 174.66 Thousand CAD | 404.19% |
| 2019 Q4 | 34.64 Thousand CAD | -55.26% |
| 2019 FY | 34.64 Thousand CAD | -33.05% |
| 2019 Q3 | 77.43 Thousand CAD | 67.02% |
| 2019 Q2 | 46.36 Thousand CAD | -69.07% |
| 2019 Q1 | 149.89 Thousand CAD | 189.67% |
| 2018 Q1 | 473.59 Thousand CAD | 1096.8% |
| 2018 FY | 51.74 Thousand CAD | 30.76% |
| 2018 Q4 | 51.74 Thousand CAD | -64.89% |
| 2018 Q3 | 147.37 Thousand CAD | -50.94% |
| 2018 Q2 | 300.39 Thousand CAD | -36.57% |
| 2017 Q2 | 16.59 Thousand CAD | -34.04% |
| 2017 FY | 39.57 Thousand CAD | 17.19% |
| 2017 Q4 | 39.57 Thousand CAD | 179.46% |
| 2017 Q3 | 14.16 Thousand CAD | -14.67% |
| 2017 Q1 | 25.16 Thousand CAD | -25.48% |
| 2016 Q2 | 52.4 Thousand CAD | -34.44% |
| 2016 Q1 | 79.93 Thousand CAD | -65.29% |
| 2016 Q3 | 44.46 Thousand CAD | -15.16% |
| 2016 FY | 33.76 Thousand CAD | -85.34% |
| 2016 Q4 | 33.76 Thousand CAD | -24.06% |
| 2015 Q4 | 230.33 Thousand CAD | 62.12% |
| 2015 Q1 | - CAD | 0.0% |
| 2015 Q2 | 1.00 CAD | 0.0% |
| 2015 Q3 | 142.07 Thousand CAD | 14207700.0% |
| 2015 FY | 230.33 Thousand CAD | 150.36% |
| 2014 FY | 92 Thousand CAD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| American Bio Medica Corporation | 1.26 Million USD | 14.191% |
| Arrayit Corporation | 1 Million USD | -8.85% |
| Atlantic International Corp. | 4.43 Million USD | 75.455% |
| Biocept, Inc. | 30.87 Million USD | 96.473% |
| Bioqual, Inc. | 56.58 Million USD | 98.076% |
| CardioGenics Holdings Inc | 231.93 Thousand USD | -369.5% |
| DermTech, Inc. | 121.93 Million USD | 99.107% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 4.18 Billion USD | 99.974% |
| HTG Molecular Diagnostics, Inc. | 17.77 Million USD | 93.875% |
| iMD Companies, Inc. | 190.13 Thousand USD | -472.703% |
| IDenta Corp. | 1.52 Million USD | 28.795% |
| Interpace Biosciences, Inc. | 13.02 Million USD | 91.637% |
| Integrative Health Technologies, Inc. | 8.25 Million USD | 86.804% |
| InVitro International | 1.53 Million USD | 29.015% |
| Lumos Diagnostics Holdings Limited | 26.83 Million USD | 95.943% |
| Many Bright Ideas Technologies Inc. | 2312.00 USD | -46998.616% |
| Medical Imaging Corp. | 4.19 Million USD | 74.022% |
| NovelStem International Corp. | 2.25 Million USD | 51.701% |
| Optigenex Inc. | 1.88 Million USD | 42.333% |
| PharmChem, Inc. | 2.76 Million USD | 60.626% |
| Proteome Sciences plc | 14.58 Million USD | 92.535% |
| Response Genetics, Inc | 48.88 Million USD | 97.772% |
| Rennova Health, Inc. | 20.57 Million USD | 94.707% |
| RushNet, Inc. | 6.04 Million USD | 81.994% |
| ScreenPro Security Inc. | 1.26 Million USD | 13.671% |
| Stella Diagnostics Inc. | 472.42 Thousand USD | -130.497% |
| StageZero Life Sciences Ltd. | 700.65 Thousand USD | -55.415% |
| Todos Medical Ltd. | 15.26 Million USD | 92.867% |